Shpitz B, Zimlichman S, Zemer R, Bomstein Y, Zehavi T, Liverant S, Bernehim J, Kaufman Z, Klein E, Shapira Y, Klein A
Department of Surgery B, Sapir Medical Center and Sackler School of Medicine, Kfar Sava, Israel.
Breast Cancer Res Treat. 1999 Nov;58(1):65-9. doi: 10.1023/a:1006394209922.
Telomerase plays an important role in maintaining the stability of the chromosomes. Activity of telomerase has been detected in proliferating and immortalized cell lines and in a number of malignant tumors including invasive breast cancer. The aim of the study was to examine telomerase activity in ductal carcinoma in situ (DCIS), which is considered to be a precursor lesion of infiltrating breast carcinoma, using a PCR-based telomerase activity protocol (TRAP). We examined 35 samples obtained from histologically confirmed breast biopsies, including 13 normal breast tissues, 11 infiltrating ductal carcinoma (IDC), nine DCIS, and two DCIS with microinvasion. Telomerase activity was demonstrated in 8/9 samples of DCIS, both samples of DCIS with microinvasion, and all but one sample of IDC. Normal breast tissue had no demonstrable telomerase activity. Our results indicate that telomerase is activated frequently in early breast carcinogenesis, although its utilization as a biomarker in DCIS is questionable.
端粒酶在维持染色体稳定性方面发挥着重要作用。在增殖细胞系和永生化细胞系以及包括浸润性乳腺癌在内的多种恶性肿瘤中均检测到了端粒酶活性。本研究的目的是使用基于聚合酶链反应的端粒酶活性检测方法(TRAP),检测导管原位癌(DCIS)中的端粒酶活性,DCIS被认为是浸润性乳腺癌的前体病变。我们检查了35份经组织学证实的乳腺活检样本,包括13份正常乳腺组织、11份浸润性导管癌(IDC)、9份DCIS以及2份伴有微浸润的DCIS。在9份DCIS样本中的8份、2份伴有微浸润的DCIS样本以及除1份样本外的所有IDC样本中均检测到了端粒酶活性。正常乳腺组织未检测到明显的端粒酶活性。我们的结果表明,端粒酶在早期乳腺癌发生过程中频繁被激活,尽管其作为DCIS生物标志物的用途存在疑问。